Product Images Advair Diskus
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 17 images provide visual information about the product associated with Advair Diskus NDC 21695-197 by Rebel Distributors Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1. Cumulative Incidence of Asthma-Related Deaths in the 28-Week Salmeterol Multi-center Asthma Research Trial (SMART), by Duration of Treatment - 9e0bdea8 df9b 4873 b24b 919cebff5edd 01
fluticasone propionate chemical structure - 9e0bdea8 df9b 4873 b24b 919cebff5edd 02
salmeterol xinafoate chemical structure - 9e0bdea8 df9b 4873 b24b 919cebff5edd 03
Figure 2. Mean Percent Change From Baseline in FEV1 in Patients With Asthma Previously Treated With Either Inhaled Corticosteroids or Salmeterol (Study 1) - 9e0bdea8 df9b 4873 b24b 919cebff5edd 04
Figure 3. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - 9e0bdea8 df9b 4873 b24b 919cebff5edd 05
This appears to be a description of an asthma medication called "ADVAIR DSKIS 100/E0" and its components, including "Saimeteni0imcy" and "Futasone prpitat 100 g ke caly". It also lists various dosages and references a "Baseline".*
Figure 4. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - 9e0bdea8 df9b 4873 b24b 919cebff5edd 06
Figure 5. Predose FEV1: Mean Percent Change From Baseline in Patients With Chronic Obstructive Pulmonary Disease - 9e0bdea8 df9b 4873 b24b 919cebff5edd 07
Figure 6. Two-Hour Postdose FEV1: Mean Percent Changes From Baseline Over Time in Patients With Chronic Obstructive Pulmonary Disease - 9e0bdea8 df9b 4873 b24b 919cebff5edd 08
This appears to be a record of medication dosages and their impact on a patient's FEV (Forced Expiratory Volume). The three medications mentioned are Advair Diskus 250/50, Fluticasone Propionate 250 mcg/day, and a placebo. The numeric values next to each medication appear to be the patient's baseline FEV before the medication is taken (in liters). The last section of the text appears to be some sort of chart or table, with numerical values listed for each medication, but the context is unclear.*
Diskus parts - 9e0bdea8 df9b 4873 b24b 919cebff5edd 09
The text appears to be a list of items or features of an unknown product. The item includes a "lever," "mouthpiece," "dose indicator," "thumb grip," and an "outer case." It is not clear what type of product these items belong to.*
Figure 1 - 9e0bdea8 df9b 4873 b24b 919cebff5edd 10
Figure 2 - 9e0bdea8 df9b 4873 b24b 919cebff5edd 11
Figure 3 - 9e0bdea8 df9b 4873 b24b 919cebff5edd 12
Figure 4 - 9e0bdea8 df9b 4873 b24b 919cebff5edd 13
Figure 5 - 9e0bdea8 df9b 4873 b24b 919cebff5edd 14
Figure 6 - 9e0bdea8 df9b 4873 b24b 919cebff5edd 15
Advair 250/50mcg - 9e0bdea8 df9b 4873 b24b 919cebff5edd 16
This is a description of a medication with the product ID RA019601. It is a prescription drug called Advair Diskus 250/50mcg and comes in a powder inhaler with lactose. The inhaler contains 250mcg of fluticasone propionate and 72.5mcg of salmeterol xinafoate, equivalent to 50mcg of salmeterol base. The package insert has further details, and it is manufactured by Glaxo Operations UK Ltd in England. It is distributed in Thousand Oaks, CA and must be kept out of the reach of children.*
Advair 500/50mcg - 9e0bdea8 df9b 4873 b24b 919cebff5edd 17
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.